ArticleBMC cancer2023

Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020.

Timothée Olivier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.